CN104606537A - 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 - Google Patents
改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 Download PDFInfo
- Publication number
- CN104606537A CN104606537A CN201510008276.9A CN201510008276A CN104606537A CN 104606537 A CN104606537 A CN 104606537A CN 201510008276 A CN201510008276 A CN 201510008276A CN 104606537 A CN104606537 A CN 104606537A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicated diet
- chemotherapy
- benefiting
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000037213 diet Effects 0.000 title claims abstract description 47
- 235000005911 diet Nutrition 0.000 title claims abstract description 47
- 238000002512 chemotherapy Methods 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 230000002107 myocardial effect Effects 0.000 title abstract description 4
- 208000037906 ischaemic injury Diseases 0.000 title abstract 2
- 241000282465 Canis Species 0.000 claims abstract description 29
- 210000000582 semen Anatomy 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 239000012567 medical material Substances 0.000 claims description 47
- 239000008280 blood Substances 0.000 claims description 41
- 210000004369 blood Anatomy 0.000 claims description 40
- 208000031225 myocardial ischemia Diseases 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 230000006378 damage Effects 0.000 claims description 39
- 239000003814 drug Substances 0.000 claims description 31
- 241000287828 Gallus gallus Species 0.000 claims description 28
- 241000282894 Sus scrofa domesticus Species 0.000 claims description 27
- 210000001550 testis Anatomy 0.000 claims description 27
- 241000218989 Trichosanthes Species 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 8
- 241000234314 Zingiber Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 7
- 238000010411 cooking Methods 0.000 claims description 7
- 238000005336 cracking Methods 0.000 claims description 7
- 239000008157 edible vegetable oil Substances 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000007790 scraping Methods 0.000 claims description 7
- 241000594394 Hedyotis Species 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 210000003899 penis Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 239000002585 base Substances 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010048610 Cardiotoxicity Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 231100000259 cardiotoxicity Toxicity 0.000 description 3
- 230000007681 cardiovascular toxicity Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000522226 Campylotropis Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000689815 Nanocnide Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000035286 Spontaneous Remission Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- CUXYLFPMQMFGPL-BGDVVUGTSA-N (9Z,11E,13Z)-octadecatrienoic acid Chemical compound CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000722949 Apocynum Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- 241001609679 Cuscuta japonica Species 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 244000273256 Phragmites communis Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000054452 Takifugu ocellatus Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000975594 Trichosanthes rosthornii Species 0.000 description 1
- ZKEKDTIKFVCKMW-UHFFFAOYSA-N Trifolin Natural products OCC1OC(Oc2cc(O)ccc2C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O ZKEKDTIKFVCKMW-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000009465 diaoxinxuekang Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000915 fish venom Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 231100000731 ichthyotoxin Toxicity 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-DTGCRPNFSA-N kaempferol 3-O-beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-DTGCRPNFSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229940093252 sorbitrate Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- CUXYLFPMQMFGPL-UYWAGRGNSA-N trichosanic acid Natural products CCCCC=C/C=C/C=CCCCCCCCC(=O)O CUXYLFPMQMFGPL-UYWAGRGNSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了改善化疗所致心肌缺血损伤的益气养血药膳及制备方法,主要由下列原料药制备而成,均为重量份:黄芪12-24;芦根10-20;当归9-15;鹿茸5-10;猪心20-30;石见穿9-12;罗布麻8-12;白花蛇舌草5-9;甘草10-15;狗肾15-30;葛根10-16;菟丝子6-10;栝楼子6-10;乌骨鸡30-50。本发明提供的药膳组方科学,制备方法简单,安全有效,可长期服用。
Description
技术领域
本发明涉及食品保健品领域,特别是涉及改善化疗所致心肌缺血损伤的益气养血药膳及制备方法。
背景技术
化疗是化学药物治疗的简称,是利用化学药物阻止癌细胞的增殖、浸润、转移,直至最终杀灭癌细胞的一种治疗方式。由于化疗药物的选择性不强,在杀灭癌细胞的同时也会不可避免地损伤人体正常的细胞,从而出现药物的不良反应。因此,在接受化疗药物的时候,一方面希望能够达到最佳的抗肿瘤作用,另一方面也要注意预防和识别化疗药物的不良反应。化疗药物对心脏的毒副作用日益引起临床的重视。造成心脏毒性的化疗药物主要是蒽环类药物,主要是以ADM为代表的。另外,高剂量的CTX、MMC、DDP、5FU、阿糖胞苷等化疗药物也可能引起心脏毒性。其引起的心脏毒副作用包括可致充血性心衰的心肌病、心律失常、心肌缺血性改变、诱发心肌梗死等。心肌缺血的主要临床表现有:1.劳累或精神紧张时出现胸骨后或心前区闷痛,或紧缩样疼痛,并向左肩、左上臂放射,持续3~5分钟,休息后自行缓解者,时伴有大汗。2.体力活动时出现胸闷、心悸、气短,休息时自行缓解者。3.出现与运动有关的咽喉痛及烧灼感、紧缩感,牙痛等。4.饱餐、寒冷、饮酒后出现胸痛、胸闷者。5.夜晚睡眠枕头低时,感到胸闷憋气,需要高枕卧位方感舒适者;熟睡、或白天平卧时突然胸痛、心悸、呼吸困难,需立即坐起或站立方能缓解者。6.性生活或用力排便时出现心慌、胸闷、气急或胸痛不适。7.突发的心动过缓、血压降低或晕厥者。
公布号CN 102512615 A(申请号201110420159.5)的中国专利文献公开了一种用于癌症恢复期的中药组合物,所述中药组合物以黄芪、党参、鸡血藤为主,配之以当归、熟地黄、阿胶等中药以补血活血、填精充髓为法,同时配以女贞子、何首乌、枸杞子、白术、茯苓、扁豆、山萸肉、骨碎补、鸡内金、生麦芽、陈皮等多味补肾益肝健脾、生津润肺、除湿消食的中药,达到为机体补益气血,滋生精髓,脾以和胃,扶正以祛的功效。公布号CN 103893285 A(申请号201210580478.7)的中国专利文献公开了一种中药组合物在制备治疗放化疗后肾毒性和心脑血管疾病药物中的应用,该中药组合物组方为大黄、黄芪和丹参。实验证实,该中药组合物有效治疗和缓解肿瘤放化疗后引起的肾脏毒性,同时对缺血性心脑血管疾病有明显的治疗效果,表现在减小脑梗死范围,改善脑缺血损伤,减少心肌缺血再灌注大鼠心肌的梗死面积,降低MDA和NOS的含量等。公布号CN 103816231 A(申请号201410095514.X)的中国专利文献公开了一种减轻放、化疗引起心脏毒性症状的中药配方及其制备方法,由以下原料组成:甘草、白药子、和血丹、野辣蓼、毛花点草、三匹叶、凤仙花、木芙蓉花、牛奶柴、红天葵、石胆草、山桂花;所述原料由以下重量份数配比组成:甘草5g、白药子8g、和血丹8g、野辣蓼6g、毛花点草12g、三匹叶4g、凤仙花6g、木芙蓉花8g、牛奶柴5g、红天葵10g、石胆草3g、山桂花6g。
化疗所造成的副作用中,可能会出现心肌缺血症状,影响患者身体健康,现有的治疗方法中,针对此方面的治疗药物比较少,西药大多比较昂贵,加强对该方面的中药配方研究是非常有必要的。
发明内容
针对现有技术的问题,本发明的目的是提供一种效果显著、服用安全适用性广的改善化疗所致心肌缺血损伤的益气养血药膳。
本发明的技术方案是:
改善化疗所致心肌缺血损伤的益气养血药膳,主要由下列原料药制备而成,均为重量份:黄芪12-24;芦根10-20;当归9-15;鹿茸5-10;猪心20-30;石见穿9-12;罗布麻8-12;白花蛇舌草5-9;甘草10-15;狗肾15-30;葛根10-16;菟丝子6-10;栝楼子6-10;乌骨鸡30-50。
优选的是:黄芪16-20;芦根12-18;当归11-13;鹿茸6-9;猪心22-28;石见穿10-11;罗布麻9-11;白花蛇舌草6-8;甘草11-14;狗肾20-25;葛根12-14;菟丝子7-9;栝楼子7-9;乌骨鸡35-45。
更加优选的是:黄芪18;芦根15;当归12;鹿茸7.5;猪心25;石见穿10.5;罗布麻10;白花蛇舌草7;甘草12.5;狗肾22.5;葛根13;菟丝子8;栝楼子8;乌骨鸡40。
所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其步骤如下:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤,晾干备用;
(2)将菟丝子和栝楼子,加水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.2-0.4倍的黄酒(优选的:加入药材量0.3倍的黄酒)拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续10-15分钟(优选的:持续13分钟),转小火煎煮,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,步骤(1)小火烘烤10-30分钟(优选的:烘烤15-25分钟;更加优选的:烘烤20分钟)。
所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,步骤(2)加水量为药材重量的3-6倍(优选的:加水量为药材重量的4-5倍;更加优选的:加水量为药材重量的4.5倍)。
所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,步骤(3)粉碎过80-120目筛(优选的:粉碎过90-110目筛;更加优选的:粉碎过100目筛)。
所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,步骤(4)加凉水量为药材重量的7-10倍(优选的:加凉水量为药材重量的8-9倍;更加优选的:加凉水量为药材重量的8.5倍)。
所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,步骤(4)小火煎煮30-50分钟(优选的:小火煎煮35-45分钟;更加优选的:小火煎煮40分钟)。
本发明还提供了所述的益气养血药膳在制备改善化疗所致心肌缺血损伤的药物时的应用。
本发明提供的改善化疗所致心肌缺血损伤的益气养血药膳配方科学,制备方法简单。除此之外,它的优良之处还表现在:
1、本发明所选用药材,均无任何毒副作用,安全有效,可长期服用;
2、依据中医辨证原则,有益气固表、活血止痛的功效,可改善心肌缺血症;
3、本发明所得各种剂型,针对性强,疗效显著,服用方便。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
本发明所用主要中药原料的药理如下:
黄芪:性甘,微温。归肺、脾、肝、肾经。有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。一般用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等。
芦根:基原:为禾本科植物芦苇的根茎。春、夏,秋挖取,洗净泥土,剪去残茎、芽及节上须根,剥去膜状叶,晒干。或埋于湿沙中以供鲜用。性味:甘,寒。归经:入肺、胃经。功能主治:清热,生津,除烦,止呕。治热病烦渴,胃热呕吐,噎膈,反胃,肺痿,肺痈。并解河豚鱼毒。
当归:性味与归经:甘、辛,温。归肝、心、脾经。有补血活血,调经止痛,润肠通便的功效。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
鹿茸:性味与归经:甘、咸,温。归肾、肝经。功能与主治:壮肾阳,益精血,强筋骨,调冲任,托疮毒。用于肾阳不足,精血亏虚,阳痿滑精,宫冷不孕,赢瘦,神疲,畏寒,眩晕,耳鸣,耳聋,腰脊冷痛,筋骨痿软,崩漏带下,阴疽不敛。
猪心:性味:甘咸,平。归经:《随息居饮食谱》:"入心经。"功能主治:治惊悸,怔忡,自汗,不眠。
石见穿:基原:为唇形科植物紫参的全草。夏至到处暑间采收。化学成份:全草含甾醇、三萜成分、氨基酸。根含水苏糖。性味:《苏州本产药材》:"苦辛,平。"功能主治:治噎膈,痰喘,肝炎,赤白带,痈肿,瘰疬。
罗布麻:基原:为夹竹桃科罗布麻属植物罗布麻的叶。成分:叶含槲皮素,异槲皮苷,金丝桃苷,三叶豆苷,云英苷,芸香苷,右旋儿茶素,蒽醌,以及谷氨酸、丙氨酸等多种氨基酸。药性:甘、微苦,凉。功用主治:清热,平肝,安神,利水。主治高血压病,眩晕,头痛,心悸,失眠,水肿尿少。
白花蛇舌草:基原:为茜草科耳草属植物白花蛇舌草的全草。夏秋采集,洗净,鲜用或晒干。性味:甘、淡,凉。归经:入胃、大肠、小肠经。功能主治:清热解毒,利尿消肿,活血止痛。用于肠痈(阑尾炎),疮疖肿毒,湿热黄疸,小便不利等症;外用治疮疖痈肿,毒蛇咬伤。
甘草:基原:为豆科甘草属植物甘草的根和根状茎。性味:甘,平。归经: 入脾、胃、肺经。功能主治:清热解毒,润肺止咳,调和诸药;炙甘草能补脾益气。主治咽喉肿痛,咳嗽,脾胃虚弱,胃、十二指肠溃疡,肝炎,癔病,痈疖肿毒,药物及食物中毒。
狗肾:基原:为犬科动物狗的肾脏。化学成份:含雄性激素、蛋白质、脂肪。性味:味甘;咸;性温。归经:肾经。功能主治:补肾温阳。主肾虚身冷。
葛根:性味: 甘、辛,凉。归经: 归脾、胃经。功效: 解肌退热,生津,透疹,升阳止泻。主治: 用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻;高血压颈项强痛。
菟丝子:基原:为旋花科植物菟丝子或大菟丝子的种子。性味与归经:辛、甘,平。归肝、肾、脾经。有补益肝肾,固精缩尿,安胎,明目,止泻的功效。外用消风祛斑。用于肝肾不足,腰膝酸软,阳痿遗精,遗尿尿频。肾虚胎漏,胎动不安,目昏耳鸣,脾肾虚泻;外治白癜风。
栝楼子:基原:为葫芦科植物栝楼或双边栝楼、大子栝楼等的种子。化学成份:栝楼仁含甙、皂甙、有机酸及其盐类(如草酸钙)、树胶、树脂、脂肪油及色素等。脂肪油含率约为26%,其中饱和脂肪酸占30%,不饱和者约占66.5%;不饱和脂肪酸以栝楼酸为主。性味:甘,寒。归经:入肺、胃、大肠经。功能主治:润肺,化痰,滑肠。治痰热咳嗽,燥结便秘,痈肿,乳少。
乌骨鸡:基原:为雉科动物乌骨鸡的肉或除去内脏的全体。性味:甘,平。归经:入肝、肾经。功能主治:养阴退热。治虚劳骨蒸羸瘦,消渴,脾虚滑泄,下痢口噤,崩中,带下。
实施例1改善化疗所致心肌缺血损伤的益气养血药膳,主要由下列原料药制备而成:黄芪12g,芦根10g,当归9g,鹿茸5g,猪心20g,石见穿9g,罗布麻8g,白花蛇舌草5g,甘草10g,狗肾15g,葛根10g,菟丝子6g,栝楼子6g,乌骨鸡30g。上述改善化疗所致心肌缺血损伤的益气养血药膳的制备方法是:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤10分钟,晾干备用;
(2)将菟丝子和栝楼子,加入药材重量3倍的水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.2倍的黄酒拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎过80目筛,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加入药材重量7倍的凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续10分钟,转小火煎煮30分钟,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
实施例2改善化疗所致心肌缺血损伤的益气养血药膳,主要由下列原料药制备而成:黄芪24g,芦根20g,当归15g,鹿茸10g,猪心30g,石见穿12g,罗布麻12g,白花蛇舌草9g,甘草15g,狗肾30g,葛根16g,菟丝子10g,栝楼子10g,乌骨鸡50g。上述改善化疗所致心肌缺血损伤的益气养血药膳的制备方法是:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤30分钟,晾干备用;
(2)将菟丝子和栝楼子,加入药材重量6倍的水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.4倍的黄酒拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎过120目筛,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加入药材重量10倍的凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续15分钟,转小火煎煮50分钟,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
典型案例:xxx,男性,55岁。主诉:牙齿疼痛半月,吃药不能缓解;现病史:经检查后发现渐变性淋巴癌,于是进行六个疗程的化疗,期间曾出现头痛胸闷症状,休息后可缓解,随后病情加重,心烦、呼吸困难,睡眠质量差,无法控制,经医院详细检查,发现是化疗所导致的心肌缺血病。
患者服用本实例所得药膳,每次150-200g,早晚各一次,温热服用,二十天为一个疗程,患者服用一个疗程后,头痛胸闷的症状有所好转,发作次数逐渐减少,连续服用三个疗程,精神提高,身体恢复至正常,随访一年内,患者未出现复发。
实施例3改善化疗所致心肌缺血损伤的益气养血药膳,主要由下列原料药制备而成:黄芪16g,芦根12g,当归11g,鹿茸6g,猪心22g,石见穿10g,罗布麻9g,白花蛇舌草6g,甘草11g,狗肾20g,葛根12g,菟丝子7g,栝楼子7g,乌骨鸡35g。上述改善化疗所致心肌缺血损伤的益气养血药膳的制备方法是:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤15分钟,晾干备用;
(2)将菟丝子和栝楼子,加入药材重量4倍的水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.3倍的黄酒拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎过90目筛,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加入药材重量8倍的凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续13分钟,转小火煎煮35分钟,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
实施例4改善化疗所致心肌缺血损伤的益气养血药膳,主要由下列原料药制备而成:黄芪20g,芦根18g,当归13g,鹿茸9g,猪心28g,石见穿11g,罗布麻11g,白花蛇舌草8g,甘草14g,狗肾25g,葛根14g,菟丝子9g,栝楼子9g,乌骨鸡45g。上述改善化疗所致心肌缺血损伤的益气养血药膳的制备方法是:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤25分钟,晾干备用;
(2)将菟丝子和栝楼子,加入药材重量5倍的水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.3倍的黄酒拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎过110目筛,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加入药材重量9倍的凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续13分钟,转小火煎煮45分钟,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
典型案例:xxx,女,60岁。 病史:患者有直肠癌三年,手术切除后转移至腹部淋巴,经过放疗后有效控制住扩散,近期出现呼吸困难症状,遇冷时咳嗽不停,说话喘不上气,夜间睡觉时胸部闷塞呼吸不畅,去医院检查,经心电图显示,确诊为化疗所致的心肌缺血症。
服用本实例所得药膳,每次150-200g,早晚各一次,温热服用,二十天为一个疗程,患者服用一个月后,呼吸困难症状减轻,连续服用三个疗程,身体明显好转,夜间睡觉呼吸正常,抵抗力提高,可正常生活。
实施例5改善化疗所致心肌缺血损伤的益气养血药膳,主要由下列原料药制备而成:黄芪18g,芦根15g,当归12g,鹿茸7.5g,猪心25g,石见穿10.5g,罗布麻10g,白花蛇舌草7g,甘草12.5g,狗肾22.5g,葛根13g,菟丝子8g,栝楼子8g,乌骨鸡40g。上述改善化疗所致心肌缺血损伤的益气养血药膳的制备方法是:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤20分钟,晾干备用;
(2)将菟丝子和栝楼子,加入药材重量4.5倍的水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.3倍的黄酒拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎过100目筛,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加入药材重量8.5倍的凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续13分钟,转小火煎煮40分钟,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
试验例1 本发明所得改善化疗所致心肌缺血损伤的益气养血药膳(实施例5)的临床应用:
选取人群:根据肿瘤医院所留病例,筛选因化疗所致心肌缺血损伤的患者470例,其中女性230例,男性240例,年龄范围35-65岁,平均年龄45.7岁。
试验前,将患者随机分为两组,实验组320例和对照组150例,两组在性别、年龄、病程、病情等方面无显著差异。实验组服用本发明所得药膳,每次150-200g(视情况而定),早晚各一次,温热服用,二十天为一个疗程;对照组服用其他常规药物(丹参滴丸、硝酸甘油、消心痛、地奥心血康等)。服药期间对两组患者进行连续观察,记录症状及变化。
疗效判定标准:参照文献疗效标准,(1)显效:临床不适症全部消除,心肌供血充足,可正常生活;(2)有效:临床不适症基本消除,心肌供血稳定;(3)无效:治疗前后病情未改变或加重。
临床结果:经三个疗程的服用后,两组治疗结果如表1所示:
治疗效果:实验组:显效率66.9%,有效率31.6%,无效率1.5%,总有效率98.5%;对照组:显效率54%,有效率32%,无效率14%,总有效率86%,治疗效果低于实验组。
服用前后症状变化如表2所示:
本发明中所使用的中药,其中,黄芪的益气固表,芦根的清热生津,当归的补血活血,鹿茸的益精壮骨,猪心的治失眠惊悸,石见穿的治咳嗽肝炎,罗布麻的清热平肝,白花蛇舌草的清热解毒,甘草的清热解毒,狗肾的补肾温阳,葛根的解肌退热,菟丝子的补益肝肾,栝楼子的润肺化痰,乌骨鸡的养阴退热,诸药合用,可有效缓解化疗所致心肌缺血损伤带来的不适症,从而提高治疗效果,使得总有效率可达到98.5%。
应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例,还可以有很多变形。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (10)
1.改善化疗所致心肌缺血损伤的益气养血药膳,其特征在于,主要由下列原料药制备而成,均为重量份:黄芪12-24;芦根10-20;当归9-15;鹿茸5-10;猪心20-30;石见穿9-12;罗布麻8-12;白花蛇舌草5-9;甘草10-15;狗肾15-30;葛根10-16;菟丝子6-10;栝楼子6-10;乌骨鸡30-50。
2. 如权利要求1所述的改善化疗所致心肌缺血损伤的益气养血药膳,其特征在于,黄芪16-20;芦根12-18;当归11-13;鹿茸6-9;猪心22-28;石见穿10-11;罗布麻9-11;白花蛇舌草6-8;甘草11-14;狗肾20-25;葛根12-14;菟丝子7-9;栝楼子7-9;乌骨鸡35-45。
3.如权利要求1所述的改善化疗所致心肌缺血损伤的益气养血药膳,其特征在于,黄芪18;芦根15;当归12;鹿茸7.5;猪心25;石见穿10.5;罗布麻10;白花蛇舌草7;甘草12.5;狗肾22.5;葛根13;菟丝子8;栝楼子8;乌骨鸡40。
4.如权利要求1-3任一所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其特征在于,步骤如下:
(1)取鹿茸,大火燎去绒毛,刮净,劈成碎块,用毛刷蘸取食用油,均匀涂抹于表面,置于小火上烘烤,晾干备用;
(2)将菟丝子和栝楼子,加水煮至开裂,不断搅拌,待水液被吸尽,再加入药材量0.2-0.4倍的黄酒(优选的:加入药材量0.3倍的黄酒)拌匀,取出干燥;
(3)将剩余药材(除猪心、狗肾和乌骨鸡),洗净,略浸,润透后,切片,干燥,与步骤(1)(2)所得药材一起粉碎,装入透析袋内;
(4)取猪心、狗肾和乌骨鸡,加碱水洗净,再用清水洗涤,润软后切片,与步骤(3)所得透析袋一起加凉水共煮,放入姜丝、葱花及料酒,大火煮开,持续10-15分钟(优选的:持续13分钟),转小火煎煮,不断搅拌,关火前加入食盐,混合均匀,即得药膳。
5.如权利要求4所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其特征在于,步骤(1)小火烘烤10-30分钟(优选的:烘烤15-25分钟;更加优选的:烘烤20分钟)。
6.如权利要求4所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其特征在于,步骤(2)加水量为药材重量的3-6倍(优选的:加水量为药材重量的4-5倍;更加优选的:加水量为药材重量的4.5倍)。
7.如权利要求4所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其特征在于,步骤(3)粉碎过80-120目筛(优选的:粉碎过90-110目筛;更加优选的:粉碎过100目筛)。
8.如权利要求4所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其特征在于,步骤(4)加凉水量为药材重量的7-10倍(优选的:加凉水量为药材重量的8-9倍;更加优选的:加凉水量为药材重量的8.5倍)。
9.如权利要求4所述的改善化疗所致心肌缺血损伤的益气养血药膳的制备方法,其特征在于,步骤(4)小火煎煮30-50分钟(优选的:小火煎煮35-45分钟;更加优选的:小火煎煮40分钟)。
10.如权利要求1-3任一所述的益气养血药膳在制备改善化疗所致心肌缺血损伤的药物时的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510008276.9A CN104606537A (zh) | 2015-01-08 | 2015-01-08 | 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510008276.9A CN104606537A (zh) | 2015-01-08 | 2015-01-08 | 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606537A true CN104606537A (zh) | 2015-05-13 |
Family
ID=53141358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510008276.9A Pending CN104606537A (zh) | 2015-01-08 | 2015-01-08 | 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606537A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104886476A (zh) * | 2015-06-04 | 2015-09-09 | 刘和花 | 一种适宜贫血患者服用的药膳及制法 |
-
2015
- 2015-01-08 CN CN201510008276.9A patent/CN104606537A/zh active Pending
Non-Patent Citations (1)
| Title |
|---|
| 刘月: ""当归补血汤不同剂量配比对模型大鼠急性心肌缺血保护作用的实验研究"", 《中国优秀硕士学位论文全文数据库·医药卫生科技辑》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104886476A (zh) * | 2015-06-04 | 2015-09-09 | 刘和花 | 一种适宜贫血患者服用的药膳及制法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106853149A (zh) | 一种可有效治疗肾阳虚衰及气虚血亏的新型中药组合物 | |
| CN103893738B (zh) | 一种抑制肿瘤生长中药组合物及其制备方法 | |
| CN102266532A (zh) | 一种治疗脂肪肝的药物及其制备方法 | |
| CN101983716B (zh) | 一种治疗胃及十二指肠溃疡的药物及其制备方法 | |
| CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
| CN104606537A (zh) | 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 | |
| CN104623545A (zh) | 辅助脂肪肝患者减肥的药剂及制备方法 | |
| CN104623374A (zh) | 一种治疗急性放射病的中药制剂及其制备方法 | |
| CN104623544A (zh) | 中度脂肪肝健脾燥湿中药剂及制备方法 | |
| CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 | |
| CN105194484A (zh) | 一种防治卵巢癌的中药制剂及制法 | |
| CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
| CN105327316A (zh) | 垂体前叶机能减退症的治疗药物 | |
| CN104622983A (zh) | 治疗直肠炎的中药组合物及其制备方法 | |
| CN104857415A (zh) | 一种胃癌患者服用的糯米粥及制法 | |
| CN104623385A (zh) | 治疗乳腺增生的药物复方及制备方法 | |
| CN104383334A (zh) | 一种清除肠道毒素的药物及其制备方法 | |
| CN104107304A (zh) | 一种治疗白发病的中药组合物 | |
| CN104524300A (zh) | 改善化疗所致心肌缺血损伤的药剂及制备方法 | |
| CN104491457A (zh) | 风湿性关节疼痛疏经通络药酒及制备 | |
| CN105168673A (zh) | 一种治疗舒张压升高的高血压的药物及其制备方法 | |
| CN104984149A (zh) | 一种与放疗配合使用的药物 | |
| CN105055801A (zh) | 一种医治心律失常的组合物及制法 | |
| CN104257933A (zh) | 妇女经期延长益气养阴制剂及制备方法 | |
| CN104667016A (zh) | 防治月经周期紊乱的中药药浴 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 338000 Jiangxi Province, Xinyu City Yushui District Station Road No. 125 Xinhua 4 floor residential building 1-1001 Applicant after: Li Hong Address before: 250000 Jianshe Road, Ji'nan, Shandong, No. 85 Applicant before: Li Hong |
|
| COR | Change of bibliographic data | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150513 |